Perspective Therapeutics Inc (AMEX: CATX) is 238.81% higher on its value in year-to-date trading and has touched a low of $2.05 and a high of $19.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CATX stock was last observed hovering at around $12.82 in the last trading session, with the day’s gains setting it 0.8%.
Currently trading at $13.62, the stock is 17.98% and 6.95% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.05 million and changing 6.24% at the moment leaves the stock 51.46% off its SMA200. CATX registered 145.89% gain for a year compared to 6-month gain of 178.76%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 42.62% loss in the last 1 month and extending the period to 3 months gives it a -19.41%, and is 14.55% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.24% over the week and 8.14% over the month.
Perspective Therapeutics Inc (CATX) has around 119 employees, a market worth around $918.40M and $8.84M in sales. Profit margin for the company is -270.46%. Distance from 52-week low is 564.39% and -28.50% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.28%).
The EPS is expected to grow by 42.65% this year
The shares outstanding are 67.43M, and float is at 51.79M with Short Float at 12.81%.
Perspective Therapeutics Inc (CATX) Insider Activity
The most recent transaction is an insider purchase by Hunt Jonathan Robert, the company’s Chief Financial Officer. SEC filings show that Hunt Jonathan Robert bought 1,800 shares of the company’s common stock on Jun 17 ’24 at a price of $9.81 per share for a total of $17667.0. Following the purchase, the insider now owns 35971.0 shares.
Perspective Therapeutics Inc disclosed in a document filed with the SEC on Jun 14 ’24 that Woods Lori A (Director) bought a total of 4,587 shares of the company’s common stock. The trade occurred on Jun 14 ’24 and was made at $10.90 per share for $49990.0. Following the transaction, the insider now directly holds 0.16 million shares of the CATX stock.
Still, SEC filings show that on Jun 13 ’24, Spoor Johan M. (CEO) acquired 100,000 shares at an average price of $1.17 for $0.12 million. The insider now directly holds 137,572 shares of Perspective Therapeutics Inc (CATX).
